Francesco Bertoni Selected Research

Francesco Bertoni Research Topics

Disease

69	Neoplasms (Cancer) 04/2022 - 02/2005
50	Lymphoma (Lymphomas) 01/2022 - 04/2002
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2005
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2020 - 11/2004
11	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020 - 01/2007
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 01/2007
7	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 08/2011
6	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 04/2002
6	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2016
6	Leukemia 10/2020 - 10/2011
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2005
5	Multiple Myeloma 10/2019 - 01/2007
4	Genetic Translocation (Chromosomal Translocation) 11/2015 - 01/2006
3	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 10/2019
3	Ovarian Neoplasms (Ovarian Cancer) 06/2012 - 10/2006
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 01/2009
2	Thrombocytopenia (Thrombopenia) 12/2022 - 01/2022
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2008
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2020 - 03/2015
2	Trisomy (Trisomies) 07/2020 - 01/2018
2	Carcinogenesis 01/2018 - 04/2015
2	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2015
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2016 - 08/2012
2	Infections 02/2012 - 03/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2010 - 07/2006
2	Uniparental Disomy 05/2008 - 07/2006
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Clinical Deterioration 01/2022
1	Neutropenia 01/2022
1	Hypertriglyceridemia 01/2022
1	Hyperphosphatemia 01/2022
1	Stomatitis 01/2022
1	Muscle Spasticity (Spastic) 01/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2008
13	Biological ProductsIBA 01/2022 - 01/2009
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2006
7	OTX015IBA 12/2019 - 04/2015
6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2011
6	Phosphotransferases (Kinase)IBA 11/2021 - 04/2015
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
6	MicroRNAs (MicroRNA)IBA 11/2021 - 02/2007
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
5	Transcription Factors (Transcription Factor)IBA 04/2022 - 01/2006
5	Anaplastic Lymphoma KinaseIBA 01/2018 - 08/2011
5	NF-kappa B (NF-kB)IBA 01/2018 - 11/2004
5	AntigensIBA 03/2015 - 07/2005
5	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2012 - 05/2007
4	venetoclaxIBA 12/2022 - 06/2019
4	ChromatinIBA 04/2022 - 03/2015
4	Histone Deacetylase InhibitorsIBA 01/2021 - 03/2015
4	Rituximab (Mabthera)FDA Link 09/2016 - 02/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 03/2005
3	UbiquitinIBA 01/2021 - 12/2007
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 09/2016
3	Ligases (Synthetase)IBA 01/2021 - 12/2007
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	Agammaglobulinaemia Tyrosine KinaseIBA 12/2019 - 09/2016
3	ibrutinibIBA 01/2018 - 01/2016
3	Everolimus FDA Link 01/2017 - 07/2012
3	Doxycycline (Periostat)FDA LinkGeneric 01/2016 - 11/2011
3	Cyclin D1IBA 11/2015 - 01/2007
2	MethyltransferasesIBA 01/2022 - 01/2017
2	Protein Isoforms (Isoforms)IBA 11/2021 - 12/2007
2	TrabectedinIBA 12/2020 - 01/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 01/2020
2	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 07/2020 - 01/2018
2	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 07/2020 - 01/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2019 - 06/2019
2	Small Interfering RNA (siRNA)IBA 10/2019 - 12/2007
2	Proteasome InhibitorsIBA 10/2019 - 06/2012
2	TOR Serine-Threonine KinasesIBA 06/2019 - 07/2012
2	pixantrone (BBR 2778)IBA 01/2019 - 01/2018
2	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2018 - 01/2018
2	Circulating Tumor DNAIBA 01/2018 - 01/2018
2	EnzymesIBA 01/2017 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 10/2008
2	Formaldehyde (Formol)FDA Link 08/2012 - 10/2008
2	ParaffinIBA 08/2012 - 10/2008
2	fludarabineIBA 03/2012 - 12/2011
1	obinutuzumabIBA 12/2022
1	Enhancer RNAsIBA 04/2022
1	Decitabine FDA Link 01/2022
1	temsirolimus FDA Link 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2021
1	Immunomodulating AgentsIBA 11/2021
1	5-(4-phenylbutoxy)psoralenIBA 02/2021
1	TRAM 34IBA 02/2021
1	PotassiumIBA 02/2021
1	Riluzole FDA LinkGeneric 02/2021
1	Potassium Channels (Potassium Channel)IBA 02/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021

Therapy/Procedure

25	Therapeutics 12/2022 - 04/2002
4	Drug Therapy (Chemotherapy) 01/2020 - 11/2011
2	Radiotherapy 03/2014 - 11/2011
2	Time-to-Treatment 01/2012 - 01/2010
2	Organ Transplantation 05/2010 - 07/2006